Treatment of Diabetic Macular Edema: An editorial

Chandra  Kumar

Journal of Diabetes & Clinical Practice
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Editorial
J Diabetes Clin Prac ,

Treatment of Diabetic Macular Edema: An editorial

Chandra Kumar

^*Corresponding Author :

Chandra kumar

Abstract

Diabetic macular edema (DME) is the most frequent cause of vision loss in patients with diabetes and is an important public health problem. Recent randomized clinical trials have shown anti-vascular endothelial growth factor (VEGF) therapy improved visual acuity and macular swelling

Keywords: anti-vascular, corticosteroids

View PDF Download PDF